It was shown that downregulation of ANGPTL4 simultaneously with upregulation of fibronectin 1 (FN1) might be implicated in anti-tumor activity of U94, an oncosuppressor, in androgen resistant prostate cancer cell lines [37]. This evidence concerns the gene FN1 and prostate carcinoma.